Thomas J. Riga - 07 Jan 2025 Form 4 Insider Report for CHIMERIX INC

Reporting relationship: COO and CCO
Issuer ticker: N/A
Reported as of: 07 Jan 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jan 2025, 14:59:09 UTC
Prior SEC filing: 16 Nov 2023
Next SEC filing: 21 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Michael Alrutz, Attorney-in-Fact

Key filing fact

Thomas J. Riga filed Form 4 for CHIMERIX INC on 10 Jan 2025.

Key facts

This page summarizes Thomas J. Riga's Form 4 filing for CHIMERIX INC.
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 Jan 2025, 14:59.

Change

Previous filing in this sequence was filed on 16 Nov 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CMRX transaction

Common Stock

Award

Transaction value: $0
Shares: +54,275
Change %: +1682%
Price: $0.000000
Shares after: 57,501
Date: 07 Jan 2025
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CMRX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +325,000
Change %
Price: $0.000000
Shares after: 325,000
Date: 07 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 325,000
Exercise price: $3.66
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The shares being reported are being issued pursuant to restricted unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 13,568 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 13,569 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 13,569 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 13,569 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant.

Footnote F2

Includes 3,226 shares acquired under the Issuer's Employee Stock Purchase Plan on September 10, 2024.

Footnote F3

One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter.